全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

MLR、WLR和OSTA指数与2型糖尿病患者骨密度的研究进展
Research Progress on MLR, WLR and OSTA Indices and Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

DOI: 10.12677/jcpm.2024.32032, PP. 217-222

Keywords: 2型糖尿病,骨密度,骨质疏松,单核细胞与淋巴细胞计数比,白细胞与淋巴细胞计数比,亚洲人骨质疏松自我筛选筛查工具(OSTA指数)
Type 2 Diabetes Mellitus
, Bone Mineral Density, Osteoporosis, Ratio of Monocyte to Lymphocyte Count, Ratio of White Blood Cell to Lymphocyte Count, Asian Osteoporosis Self-Screening Screening Tool (OSTA Index)

Full-Text   Cite this paper   Add to My Lib

Abstract:

2型糖尿病性骨质疏松(Type 2 Diabetic Osteoporosis, T2DOP)是由2型糖尿病(Type 2 Diabetes Mellitus, T2DM)导致的以骨量减少、骨微结构受损、骨强度降低和骨折风险增加为特征的肌骨系统并发症,早期无症状且发病机制复杂,诊断方法有限,患者的致残率和死亡率高。当前对T2DOP的治疗主要采用抗糖尿病药物和抗骨质疏松药物。糖尿病患者任意部位骨折风险增加达32%,髋部骨折风险增加77%。即使部分2型糖尿病患者有较高的骨密度,仍具有较高的骨折风险,而骨折风险评分可能低估其骨折风险。糖尿病患者血糖控制差和病程延长是骨折的决定性因素,跌倒是外周骨折的主要危险因素,微血管病变加速骨量丢失。糖尿病影响所有类型骨细胞,降低骨转换率,降低骨强度。为此,本文总结相关文献内容,并介绍MLR、WLR和OSTA指数与2型糖尿病患者骨密度的研究进展为今后的研究提供参考。
Type 2 diabetic osteoporosis is a musculoskeletal system complication caused by type 2 diabetes mellitus, characterized by decreased bone mass, impaired bone microstructure, decreased bone strength, and increased risk of fracture. It is asymptomatic in the early stage, with complex pathogenesis, limited diagnostic methods, and high morbidity and mortality. At present, T2DOP is mainly treated with anti-diabetic drugs and anti-osteoporosis drugs. Patients with diabetes had a 32 percent increased risk of fracture at any site and a 77 percent increased risk of hip fracture. Even if some people with type 2 diabetes have higher bone density, they still have a higher risk of fracture, and the fracture risk score may underestimate their fracture risk. Poor glycemic control and prolonged disease course in diabetic patients are the decisive factors for fracture, fall is the main risk factor for peripheral fracture, and microvascular disease accelerates bone mass loss. Diabetes affects all types of bone cells, reducing the rate of bone turnover and reducing bone strength. To this end, this paper summarizes the relevant literature and introduces the research progress of MLR, WLR and OSTA index and BMD in type 2 diabetes patients to provide reference for future research.

References

[1]  Schacter, G.I. and Leslie, W.D. (2017) Diabetes and Bone Disease. Endocrinology and Metabolism Clinics of North America, 46, 63-85.
https://doi.org/10.1016/j.ecl.2016.09.010
[2]  杨婧茹. 2型糖尿病患者外周血细胞分析与骨质疏松症的相关性研究[D]: [硕士学位论文]. 长春: 吉林大学, 2021.
https://doi.org/10.27162/d.cnki.gjlim.2021.006459
[3]  Paschou, S.A., Dede, A.D., Anagnostis, P.G., et al. (2017) Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. The Journal of Clinical Endocrinology & Metabolism, 102, 3621-3634.
https://doi.org/10.1210/jc.2017-00042
[4]  Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D., Ohlrogge, A.W. and Malanda, B. (2018) IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281.
https://doi.org/10.1016/j.diabres.2018.02.023
[5]  (1993) Consensus Development Conference: Diagnosis, Prophylaxis, and Treatment of Osteoporosis. The American Journal of Medicine, 94, 646-650.
https://doi.org/10.1016/0002-9343(93)90218-E
[6]  Aziziyeh, R., Amin, M., Habib, M., Garcia Perlaza, J., Szafranski, K., McTavish, R.K., et al. (2019) The Burden of Osteoporosis in Four Latin American Countries: Brazil, Mexico, Colombia, and Argentina. Journal of Medical Economics, 22, 638-644.
https://doi.org/10.1080/13696998.2019.1590843
[7]  Greenhill, C. (2018) Shared Variants for Osteoporosis and T2DM. Nature Reviews Endocrinology, 14, 627.
https://doi.org/10.1038/s41574-018-0095-0
[8]  Poiana, C. and Capatina, C. (2017) Fracture Risk Assessment in Patients with Diabetes Mellitus. Journal of Clinical Densitometry, 20, 432-443.
https://doi.org/10.1016/j.jocd.2017.06.011
[9]  Kurra, S., Fink, D.A. and Siris, E.S. (2014) Osteoporosis-Associated Fracture and Diabetes. Endocrinology and Metabolism Clinics of North America, 43, 233-243.
https://doi.org/10.1016/j.ecl.2013.09.004
[10]  Ra?ka Jr., I., Ra?ková, M., Zikán, V. and ?krha, J. (2017) Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus. Central European Journal of Public Health, 25, 3-10.
https://doi.org/10.21101/cejph.a4717
[11]  Lobos, S., Cooke, A., Simonett, G., et al. (2017) Assessment of Bone Mineral Density at the Distal Femur and the Proximal Tibia by Dual Energy X-Ray Absorptiometry in Individuals with Spinal Cord Injury: Precision of Protocol and Relation to Injury Duration. Journal of Clinical Densitometry, 21, 338-346.
https://doi.org/10.1016/j.jocd.2017.05.006
[12]  申丹妮, 宋飞鹏, 胥毅, 等. 能谱CT与双能X线吸收法对骨密度测定的相关性研究[J]. 中国药物与临床, 2020, 20(8): 1276-1278.
[13]  Liu, J., Liu, X., Li, Y., et al. (2018) The Association of Neutrophil to Lymphocyte Ratio, Mean Platelet Volume, and Platelet Distribution Width with Diabetic Retinopathy and Nephropathy: A Meta-Analysis. Bioscience Reports, 38, BSR20180172.
https://doi.org/10.1042/BSR20180172
[14]  Grossmann, V., Schmitt, V.H., Zeller, T., et al. (2015) Profile of the Immune and Inflammatory Response in Individuals with Prediabetes and Type 2 Diabetes. Diabetes Care, 38, 1356-1364.
https://doi.org/10.2337/dc14-3008
[15]  Huang, Y., Deng, W., Zheng, S., et al. (2018) Relationship between Monocytes to Lymphocytes Ratio and Axial Spondyloarthritis. International Immunopharmacology, 57, 43-46.
https://doi.org/10.1016/j.intimp.2018.02.008
[16]  Xiang, J., Zhou, L., Li, X., et al. (2017) Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer. Translational Oncology, 10, 33-39.
https://doi.org/10.1016/j.tranon.2016.10.006
[17]  Du, J., Chen, S., Shi, J., et al. (2017) The Association between the Lymphocyte-Monocyte Ratio and Disease Activity in Rheumatoid Arthritis. Clinical Rheumatology, 36, 2689-2695.
https://doi.org/10.1007/s10067-017-3815-2
[18]  Ginaldi, L. and De Martinis, M. (2016) Osteoimmunology and Beyond. Current Medicinal Chemistry, 23, 3754-3774.
https://doi.org/10.2174/0929867323666160907162546
[19]  Li, J.-Y., Tawfeek, H., Bedi, B., et al. (2011) Ovariectomy Disregulates Osteoblast and Osteoclast Formation through the T-Cell Receptor CD40 Ligand. Proceedings of the National Academy of Sciences of the United States of America, 108, 768-773.
https://doi.org/10.1073/pnas.1013492108
[20]  Li, Y., Toraldo, G., Li, A., et al. (2007) B Cells and T Cells Are Critical for the Preservation of Bone Homeostasis and Attainment of Peak Bone Mass in vivo. Blood, 109, 3839-3848.
https://doi.org/10.1182/blood-2006-07-037994
[21]  Sapra, L., Bhardwaj, A., Mishra, P.K., et al. (2021) Regulatory B Cells (Bregs) Inhibit Osteoclastogenesis and Play a Potential Role in Ameliorating Ovariectomy-Induced Bone Loss. Frontiers in Immunology, 12, Article 691081.
https://doi.org/10.3389/fimmu.2021.691081
[22]  Croes, M., ?ner, F.C., van Neerven, D., et al. (2016) Proinflammatory T Cells and IL-17 Stimulate Osteoblast Differentiation. Bone, 84, 262-270.
https://doi.org/10.1016/j.bone.2016.01.010
[23]  Gao, K., Zhu, W., Liu, W., et al. (2019) The Predictive Role of Monocyte-to-Lymphocyte Ratio in Osteoporosis Patient. Medicine, 98, e16793.
https://doi.org/10.1097/MD.0000000000016793
[24]  Azab, B., Jaglall, N., Atallah, J.P., Lamet, A., Raja-Surya, V., Farah, B., et al. (2011) Neutrophil-Lymphocyte Ratio as a Predictor of Adverse Outcomes of Acute Pancreatitis. Pancreatology, 11, 445-452.
https://doi.org/10.1159/000331494
[25]  Mizuno, A., Kanno, T., Hoshi, M., Shibata, O., Yano, K., Fujise, N., Kinosaki, M., Yamaguchi, K., Tsuda, E., Murakami, A., Yasuda, H. and Higashio, K. (2002) Transgenic Mice Overexpressing Soluble Osteoclast Differentiation Factor (SODF) Exhibit Severe Osteoporosis. Journal of Bone and Mineral Metabolism, 20, 337-344.
https://doi.org/10.1007/s007740200049
[26]  Grcevic, D., Lee, S.-K., Marusic, A. and Lorenzo, J.A. (2000) Depletion of CD4 and CD8 T Lymphocytes in Mice in vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation in vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis. The Journal of Immunology, 165, 4231-4238.
[27]  Kabashima, H. and Nagata, K (2001) Presence of Interleukin-4-Producing Cells for Human Bone Regeneration after Application of Guided Tissue Regeneration Membranes. Journal of Endodontics, 27, 444-448.
https://doi.org/10.1097/00004770-200107000-00002
[28]  Gannon, F.H., Valentine, B.A., Shore, E.M., Zasloff, M.A. and Kaplan, F.S. (1998) Acute Lymphocyte Infiltration Is an Extremely Early Lesion of Fibrodysplasia Ossificans Progressiva. Clinical Orthopaedics and Related Research, 346, 19-25.
https://doi.org/10.1097/00003086-199801000-00005
[29]  曾树东. 老年2型糖尿病患者骨质疏松症相关因素研究[D]: [硕士学位论文]. 济南: 山东大学, 2019.
https://doi.org/10.27272/d.cnki.gshdu.2019.000560
[30]  Zha, X.-Y., Hu, Y., Pang, X.-N., et al. (2015) Diagnostic Value of Osteoporosis Self-Assessment Tool for Asians (OSTA) and Quantitative Bone Ultrasound (QUS) in Detecting High-Risk Populations for Osteoporosis among Elderly Chinese Men. Journal of Bone and Mineral Metabolism, 33, 230-238.
https://doi.org/10.1007/s00774-014-0587-5
[31]  Chaovisitsaree, S., Namwongprom, S.N., Morakote, N., et al. (2007) Comparison of Osteoporosis Self Assessment Tool for Asian (OSTA) and Standard Assessment in Menopause Clinic, Chiang Mai. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 90, 420-425.
[32]  Subramaniam, S., Chan, C.-Y., Soelaiman, I.-N., et al. (2019) The Performance of Osteoporosis Self-Assessment Tool for Asians (OSTA) in Identifying the Risk of Osteoporosis among Malaysian Population Aged 40 Years and above. Archives of Osteoporosis, 14, Article No. 117.
https://doi.org/10.1007/s11657-019-0666-2
[33]  Park, H.M., Sedrine, W.B., Reginster, J.-Y., et al. (2003) Korean Experience with the OSTA Risk Index for Osteoporosis: A Validation Study. Journal of Clinical Densitometry, 6, 247-250.
https://doi.org/10.1385/JCD:6:3:247
[34]  Panichyawat, N. and Tanmahasamut, P. (2012) Comparison of OSTA Index and KKOS Scoring System for Prediction of Osteoporosis in Postmenopausal Women Who Attended Siriraj Menopause Clinic. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 95, 1365-1371.
[35]  张恬, 吕珊, 殷泉忠, 等. 维生素D缺乏与老年2型糖尿病患者发生骨质疏松、骨骼肌质量减少的相关性研究[J]. 中国骨质疏松杂志, 2019, 25(8): 1110-1115.
[36]  孟彩云, 庄扬名. 2型糖尿病并发骨质疏松患者胰岛素样生长因子-1、骨碱性磷酸酶及1,25 羟维生素D3表达水平及意义[J]. 临床军医杂志, 2019, 47(6): 628-629.
[37]  张静, 罗小婉, 肖琳, 等. 骨质风险评比工具以及亚洲骨质疏松自我评估工具指数在绝经后女性骨质疏松风险评估中的作用[J]. 山西医药杂志, 2021, 50(15): 2287-2289.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133